An update from Zura Bio (ZURA) is now available.
Zura Bio Limited successfully completed a private placement deal on April 22, 2024, raising approximately $112.5 million by selling Class A Ordinary Shares and Pre-Funded Warrants to institutional and accredited investors. The company sold over 18 million shares and more than 16 million pre-funded warrants at a price of $3.108 each, with the warrants exercisable at $0.001. The proceeds will be used for corporate purposes, while the company also plans to register these securities for resale, ensuring compliance and the ability to convert warrants into shares without exceeding ownership thresholds. Leading financial firms facilitated the transaction, underscoring investor confidence in Zura Bio’s growth potential.
Find detailed analytics on ZURA stock on TipRanks’ Stock Analysis page.
